Yang Cao
CIK: 0001946538
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Officer
Discretionary Trading P&L
Holdings
About Cao Yang
Cao Yang (SEC CIK 0001946538) files insider reports with the SEC as Chief Regulatory Officer of Humacyte, Inc. (HUMA).
Signal8 holds 1 ownership filing by Cao Yang, a Form 4, filed on Jan 23, 2025. Those filings report 1 transaction, the latest on Jan 21, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Cao Yang's filings is in DURHAM, NC.
Recent filings by Cao Yang
- Jan 21, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Kuznik Paul Brian, Director
- Jones Keith Anthony, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director